Scott Peters
Comptroller/Controller/Auditor bei PLIANT THERAPEUTICS, INC.
Profil
Scott Peters is currently the Vice President-Finance & Controller at Pliant Therapeutics, Inc. Prior to his current position, he worked at Alexion Pharmaceuticals, Inc. as the Executive Director & Controller from 2013 to 2021.
Mr. Peters completed his undergraduate degree at the University of California, Santa Barbara.
Aktive Positionen von Scott Peters
| Unternehmen | Position | Beginn |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01.02.2021 |
Ehemalige bekannte Positionen von Scott Peters
| Unternehmen | Position | Ende |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.02.2021 |
Ausbildung von Scott Peters
| University of California, Santa Barbara | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PLIANT THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |